The role of glatiramer acetate in the early treatment of multiple sclerosis.

Neuropsychiatric Disease and Treatment
David W Brandes

Abstract

The treatment of the underlying disease process causing multiple sclerosis has continued to evolve since the initial approval of interferon-beta-1b in 1993. Current emphasis is on early treatment, including treatment after a single clinical attack (clinically isolated syndrome). The assessment of which disease modifying medication to use as initial therapy has continued to remain a combination of science and the art of medicine. Equally important are the assessment of treatment failure and the subsequent choice of medication change. This article will present scientific information, as well as information about clinical decision making, about these choices, with emphasis on the changing role of glatiramer acetate in this process.

References

Nov 27, 2002·Neurology·M ClanetUNKNOWN European IFNbeta-1a (Avonex) Dose-Comparison Study Investigators
Mar 3, 2006·Neurology·N Koch-HenriksenUNKNOWN Danish Multiple Sclerosis Group
Nov 28, 2006·Expert Opinion on Drug Metabolism & Toxicology·Jai PerumalOmar Khan
Apr 3, 2008·Neuroepidemiology·Margitta T Kampman, Magritt Brustad
Feb 10, 2009·Journal of the Neurological Sciences·V Wee Yong
Feb 13, 2009·Current Medical Research and Opinion·David W BrandesShirley O'Leary
Mar 27, 2009·Brain : a Journal of Neurology·Jorge CorrealeMaría Inés Gaitán
Apr 3, 2009·Brain : a Journal of Neurology·Josa M FrischerHans Lassmann
Jun 16, 2009·Neurology·John F Foley, David W Brandes
Aug 12, 2009·Current Neurology and Neuroscience Reports·Bridget A Bagert
Aug 15, 2009·Current Medical Research and Opinion·Mark S FreedmanBianca Weinstock-Guttman
Oct 2, 2009·Nature Reviews. Neurology·Jordi RíoXavier Montalban
Dec 17, 2009·Multiple Sclerosis : Clinical and Laboratory Research·K Claire SimonAlberto Ascherio
Dec 24, 2009·Multiple Sclerosis : Clinical and Laboratory Research·W B Grant
Feb 6, 2010·Neurology·Suhayl Dhib-Jalbut, Steven Marks
Feb 6, 2010·Neurology·Lloyd H Kasper, Jennifer Shoemaker
Feb 6, 2010·Neurology·Michael K RackeNitin J Karandikar

❮ Previous
Next ❯

Citations

Sep 18, 2014·Journal of Neuroimmunology·Cyd Castro-RojasOlaf Stüve
Dec 21, 2012·Expert Opinion on Drug Delivery·Alessandra Lugaresi
Nov 5, 2011·Journal of Cellular and Molecular Medicine·Wenjun ZhuMike Namaka
Sep 7, 2017·Scientific Reports·Lydia Asrat HaileDaniela Verthelyi

❮ Previous
Next ❯

Software Mentioned

BiogenIdec
Rebif

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.